Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Vasospasm, Cerebral, Endothelial Dysfunction
In brief
Soluble epoxide hydrolase (sEH) is the metabolizing enzyme of epoxyeicosatrienoic acids (EETs), which may play a role in reducing neuroinflammation and regulating cerebral blood flow after subarachnoid hemorrhage (SAH). Hypotheses: Pharmacologic inhibition of the sEH enzyme is safe and will result in increased EETs availability in the blood and cerebrospinal fluid. This study is a double-blind, placebo-controlled, phase 1b randomized trial to evaluate the safety and efficacy of GSK2256294, a novel soluble epoxide hydrolase inhibitor in patients with aneurysmal SAH.
Key facts
- Study ID
- NCT03318783
- Run by
- Oregon Health and Science University
- People needed
- 20
- Starts
- 2018-05-02
- Expected to finish
- 2020-01-09
- Last updated by the study team
- 2021-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18
- Head CT evidence of subarachnoid hemorrhage
- Digital subtraction cerebral angiography or CT angiogram documenting the presence of a cerebral aneurysm.
You may not qualify if…
- Symptom onset compatible with SAH of > 3 days prior to admission to OHSU
- Absence of an indwelling external ventricular drain
- Administration of any of the following inducers/inhibitors of CYP3A4: ritonavir, indinavir, nelfinavir, saquinavir, clarithromycin, telithromycin, chloramphenicol, ketoconazole, itraconazole, nefazodone, cobicistat or enzalutamide.
- Suspected or confirmed pregnancy
- Preexisting severe neurologic deficit or condition
- Chronic renal failure requiring dialysis
- Severe terminal disease with life expectancy <6 months
- Unable to read or understand written or spoken English or Spanish
- Refusal of informed consent
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.